menu

contact
Italian Trulli

Tissue Selective
drug discovery

Bonito is a Boston-area biotech unlocking next generation targeted delivery. Using our proprietary discovery engine, we develop small molecule ligands that deliver payloads to any cell or tissue type, with a core focus on oligotherapeutic (siRNA, ASO) delivery to select tissue types.

Contact us
Italian Trulli
Italian Trulli
Italian Trulli
Italian Trulli
Italian Trulli

Harnessing the power of AI to generate novel delivery molecules

Unlocking Next Generation Delivery Vehicles

Bonito is a Boston-area biotech unlocking next generation targeted delivery. Using our proprietary discovery engine, we develop small molecule ligands that deliver payloads to any cell or tissue type, with a core focus on oligotherapeutic (siRNA, ASO) delivery to select tissue types.

Italian Trulli
Italian Trulli
Italian Trulli
Italian Trulli

experience & leadership

Bonito is led by an experienced team of entrepreneurs and innovative scientists with a track record of pioneering display technologies and oligonucleotide therapeutics.

Reach out

Our Leadership

Richard Wagner Ph.D.

Richard Wagner Ph.D.

CEO, Cofounder

Brant Binder

Brant Binder

President, Cofounder

Steve Shamah, Ph.D.

Steve Shamah, Ph.D.

CSO

Yun Ding, Ph.D.

Yun Ding, Ph.D.

SVP Head of Chemistry

Chris Kollmann

Chris Kollmann

VP Selection Sciences

Jim Weterings, Ph.D.

Jim Weterings, Ph.D.

VP Head of Oligo Discovery

Ribhu Nayar, Ph.D.

Ribhu Nayar, Ph.D.

Sr. Dir. Head of Biology

Dan Rosmarin

Dan Rosmarin

VP, Head of BD and Corporate Strategy

Want to collaborate?

If you're interested in collaborating with Bonito we'd love to hear from you!

Contact us

Find Bonito on linkedin

Connect with Bonito on Linkedin for future news and company updates.

Our Linkedin
Italian Trulli

The future of targeted delivery

© Bonito Biosciences 2025